Dupont De Nemours, Inc. · NYSE:DD
Dupont De Nemours — Q4 2025 Earnings Presentation
27 slides from Dupont De Nemours's earnings presentation, Feb 10, 2026
Slide 1: 4Q & Full Year 2025 Financial Results
4Q & Full Year 2025 Financial Results February 10, 2026
Slide 2: Overview
Overview DuPont de Nemours, Inc . (“DuPont”) completed the previously announced separation of its Electronics business (the “Electronics Separation”) into an independent public company, Qnity Electronics, Inc . (“Qnity”), by way of the distribution to DuPont's stockholders of record as of October 22
Slide 3: 2025 Highlights
2025 Highlights FY 2025 Financials Operational Highlights Successful separation of Qnity Organic sales growth driven by strength in healthcare and water end -markets Build out of leadership team for the new DuPont Strong operational execution and productivity drove EBITDA growth and Enhanced perform
Slide 4: 2026 Strategic Priorities
2026 Strategic Priorities Drive • Streamlined portfolio, well-positioned in high-growth secular markets Organic • Innovation: launched >125 new products in 2025 to support organic growth Growth • AI investments to accelerate demand generation • Driving continuous improvement; standard set of managin
Slide 5: FY 2026 Financial Guidance
FY 2026 Financial Guidance ~3% 2026 Macro Trend Assumptions Organic Net Sales Growth Global Surgical Procedures Mid-single digit growth 60 – 80 bps Global Water Intelligence Mid-single digit growth; Low -single digit growth in China Op. EBITDA Margin Expansion Global GDP >2% led by growth in Asia <2
Slide 6: 4Q 2025 Financial Highlights
4Q 2025 Financial Highlights Sales Drivers Profitability & Cash Flow Organic Sales: • Up 4% YoY on favorable mix and Net Sales Operating Growth in healthcare and water end - cost productivity, partially offset by $1.7 billion markets was more than offset by EBITDA growth investments Flat YoY continu
Slide 7: 4Q 2025 Adjusted EPS Bridge
4Q 2025 Adjusted EPS Bridge +18% Sales Drivers $0.46 $0.06 $0.02 $0.00 $0.39 ($0.01) ₊Interest, ₋Tax rate net ₊ Favorable mix ₊Exchange +$0.04 ₊ Cost Productivity +$0.02 loss ₋ Growth Investments 4Q24 Segments Corporate Tax Rate Other 4Q25 Adjusted EPS Below -the -Line Adjusted EPS 7
Slide 8: Healthcare & Water Technologies
Healthcare & Water Technologies 4 Q NetVol Sales (+2%), Price (-1%), Currency (0%), Portfolio (0%) 4 Q 2025 YoY Highlights Organic Growth +3% $ in Millions (+5% ex order timing headwinds, primarily in Water Technologies) +4% +3% flat +1% flat $821 $790 Organic Sales by Line of Business 1 4Q24 Volume
Slide 9: Diversified Industrials
Diversified Industrials 4 Q NetVol Sales (+2%), Price (-1%), Currency (0%), Portfolio (0%) 4 Q 2025 YoY Highlights Organic Growth -4% (-2% ex order timing head winds, $ in Millions primarily in Industrial Technologies) -3% $899 $872 -4% flat +1% flat Organic Sales by Line of Business 1 4Q24 Volume P
Slide 10: 1Q and FY 2026 Guidance
1Q and FY 2026 Guidance Key Metrics 1Q 2026 FY 2026 Key Assumptions Net Sales ~$1.67 billion $7.075 - $7.135 billion • 1Q’26: Assumes ~2 percent organic sales growth YoY, along with foreign currency tailwinds of ~2 percent Operating • FY’26: Assumes ~3 percent organic sales growth YoY, ~$395 million
Slide 11: Appendix
Appendix 11
Slide 12: 4Q 2025 Net Sales Bridge
4Q 2025 Net Sales Bridge Sales Drivers Organic Sales -1% Volume -1% Price flat flat flat +1% +3% -4% $1,689 $1,693 ₊ Euro, JPY $ in Millions Healthcare Building Technologies Technologies Water Industrial Technologies Technologies 4Q24 Portfolio Currency Healthcare Diversified Industrials 4Q25 & Wate
Slide 13: FY 2025 Financial Highlights
FY 2025 Financial Highlights Sales Drivers Profitability & Cash Flow Organic Sales: • Up 6% YoY on organic growth and Net Sales Growth in healthcare and water end - Operating EBITDA productivity, partially offset by $6.8 billion markets, partially offset by softness in growth investments +2% constru
Slide 14: FY 2025 Net Sales Bridge
FY 2025 Net Sales Bridge Sales Drivers Organic Sales +2% Volume +3% Price -1% +2% flat flat +7% -2% $6,719 $6,849 ₊ Donatelle $ in Millions acquisition (Healthcare Healthcare Building Technologies) Technologies Technologies ₋ PVexitproduct line (Industrial Water Technologies Industrial Technologies
Slide 15: 2026 Segment Expectations
2026 Segment Expectations Healthcare & Water Technologies Diversified Industrials 1Q2026 1Q2026 • Expect low to mid -single digit organic sales growth year -over- • Expect slight organic sales growth year -over-year year • Growth in aerospace and automotive end -markets partially 3Q Operating EBITDA
Slide 16: Additional Modeling Guidance
Additional Modeling Guidance Vol (+2%), Price (-1%), Currency (0%), Additional Portfolio (0%)Modeling Guidance Base Tax Rate ~26% - 1Q 26 ~25% -26% - FY 26 D&A ~$625 million, pre -tax Depreciation ~$350 million, pre -tax Intangible Amortization ~$275 million, pre -tax Interest Expense, net ~$110 mil
Slide 17: Medium-term targets
Medium -term targets Expected performance from FY2025 – FY2028 Organic Growth 3 – 4% CAGR Driving innovation and capitalizing Organic Net Sales on long -term market tailwinds Margin Expansion 150 – 200bps Sustaining strong margins through continuous Improvement improvement and a high -growth asset m
Slide 18: Non-GAAP Financial Measures
Non -GAAP Financial Measures : Unless otherwise indicated, all financial metrics presented reflect continuing operations only . This communication includes information that does not conform to accounting principles generally accepted in the United States of America (“U.S. GAAP”) and are considered n
Slide 19: Non-GAAP Financial Measures Definitions
Non -GAAP Financial Measures Definitions Organic Sales Organic Sales is defined as net sales excluding the impacts of currency and portfolio . Adjusted Earnings Adjusted Earnings is defined as income from continuing operations excluding the after -tax impact of significant items, after -tax impact o
Slide 20: Transaction Adjusted Free Cash Flow
Non -GAAP Financial Measures Definitions (Continued) Transaction Adjusted Free Cash Flow & Transaction Adjusted Free Cash Flow Conversion Management believes supplemental non -GAAP financial measures including Transaction -Adjusted Free Cash Flow and Transaction -Adjusted Free Cash Flow Conversion (
Slide 21: Selected Financial Information and Non-GAAP Measures
Selected Financial Information and Non -GAAP Measures 21
Slide 22: Selected Financial Information and Non-GAAP Measures
Selected Financial Information and Non -GAAP Measures 22
Slide 23: Selected Financial Information and Non-GAAP Measures
Selected Financial Information and Non -GAAP Measures 23
Slide 24: Selected Financial Information and Non-GAAP Measures
Selected Financial Information and Non -GAAP Measures 24
Slide 25: Selected Financial Information and Non-GAAP Measures
Selected Financial Information and Non -GAAP Measures 25
Slide 26: Selected Financial Information and Non-GAAP Measures
Selected Financial Information and Non-GAAP Measures 26
Slide 27: © 2026 DuPont de Nemours, Inc. All rights reserved
© 2026 DuPont de Nemours, Inc. All rights reserved. DuPont , the DuPont Oval Logo, and all products, unless otherwise noted, denoted with , ℠ or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.